Drawing for ARMING HUMANITY WITH WEAPONS TO FIGHT DRUG RESISTANT INFECTIONS

USPTO serial 87777988

ARMING HUMANITY WITH WEAPONS TO FIGHT DRUG RESISTANT INFECTIONS

Reviewed by CopyMark Law Group

Reg. 6531066Status 700Renewal
Filing date
Status date
Registration date
Oct 19, 2021
Examiner
KENEALY, NATALIE LANGFORD
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ARMING HUMANITY WITH WEAPONS TO FIGHT DRUG RESISTANT INFECTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jonathan R. Lagarenne

Jonathan R. Lagarenne Fox Rothschild LLP997 Lenox Drive, Bldg. 3Lawrenceville, NJ 08648-2311UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Drug delivery agents in the form of dissolvable, coatings for medical implants that facilitate the delivery of pharmaceutical preparations; chemical ingredients in the nature of antimicrobial substances sold as a component ingredient of antimicrobial coatings to treat, inhibit and prevent the growth of viruses, fungus, mold, bacteria, spores and biofilms on medical implants; antimicrobial coatings to treat, inhibit and prevent the growth of viruses, fungus, mold, bacteria, spores and biofilms on the surfaces of medical, dental and veterinary implants; Chemical ingredients in the nature of antimicrobial substances and preparations for medical purposes for treating, inhibiting and preventing viruses, fungus, mold, bacteria, spores and biofilms; chemical ingredients in the nature of antimicrobial substances sold as a component ingredient of irrigation solutions, namely, medical cleansers for wounds; biostatic antimicrobial preparations for treating, inhibiting and preventing viruses, fungus, mold, bacteria, spores and biofilms; wound antiseptic, medicated cleansers for skin and wounds, and wound irrigation agents, namely, medicated wash and sterilizing preparations; medical cleansers for skin; cleansing solutions for medical use; all purpose disinfecting preparations; topical gel for medical and therapeutic treatment of wounds and other skin disorders; antiseptic preparations; antiseptics; Antibacterial and antibiotic preparations for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 11, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 19, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 16, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 15, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 16, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 12, 2021IUAFUSE AMENDMENT FILED—
Aug 12, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 26, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 25, 2021EX5GSOU EXTENSION 5 GRANTED—
Feb 21, 2021EXT5SOU EXTENSION 5 FILED—
Feb 21, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 22, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 20, 2020EX4GSOU EXTENSION 4 GRANTED—
Aug 20, 2020EXT4SOU EXTENSION 4 FILED—
Aug 20, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 29, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 19, 2020EX3GSOU EXTENSION 3 GRANTED—
Feb 19, 2020EXT3SOU EXTENSION 3 FILED—
Feb 19, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 19, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 30, 2019NOACCORRECTED NOA E-MAILED—
Aug 28, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 27, 2019EX2GSOU EXTENSION 2 GRANTED—
Aug 27, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 27, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 19, 2019EXT2SOU EXTENSION 2 FILED—
Aug 19, 2019DRRRDIVISIONAL REQUEST RECEIVED—
Aug 19, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 19, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 23, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 21, 2019EX1GSOU EXTENSION 1 GRANTED—
Feb 21, 2019EXT1SOU EXTENSION 1 FILED—
Feb 21, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 21, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 26, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 26, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 6, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 21, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 14, 2018DOCKASSIGNED TO EXAMINER—
Apr 5, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 3, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance